Operating Income: The income after operating expenses.
Abbott Laboratories (ABT) had Operating Income of $1.78B for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$10.24B |
|
$1.59B |
|
$4.56B |
|
$5.68B |
|
$8.46B |
|
|
Operating Income |
$1.78B |
$15.00M |
|
$1.79B |
|
$1.79B |
|
$1.59B |
|
$1.59B |
|
$1.59B |
|
$1.59B |
|
$1.78B |
|
$2.59B |
|
1.74B |
|
1.75B |
|
$0.92 |
|
$0.91 |
|
| Balance Sheet Financials | |
$22.67B |
|
$10.15B |
|
$50.54B |
|
$73.21B |
|
$13.84B |
|
$13.60B |
|
$20.55B |
|
$34.39B |
|
$38.83B |
|
$6.33B |
|
$38.83B |
|
1.73B |
|
| Cash Flow Statement Financials | |
$7.26B |
|
$-3.13B |
|
$-7.09B |
|
$9.88B |
|
$6.90B |
|
$-2.99B |
|
$644.00M |
|
$-3.56B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.64 |
|
-- |
|
-- |
|
0.26 |
|
0.38 |
|
55.51% |
|
17.38% |
|
17.38% |
|
-- |
|
17.53% |
|
15.56% |
|
$5.06B |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.69 |
|
1.56 |
|
57.69 |
|
4.11% |
|
25.17% |
|
2.18% |
|
3.04% |
|
$22.39 |
|
$2.89 |
|
$4.15 |
|